Showing results (501-510 of 910) with videos related to

Sort By:
Pageof 91
American Heart Journal|August 1, 2006
Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery diseaseDavid Aguilar, Marian R Fisher, Christopher M O'Connor, et al.
American Heart Journal|August 10, 2005
Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic studyScott D Solomon, Hicham Skali, Mikhail Bourgoun, et al.
International Journal of Cardiology|January 20, 2012
Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trialC Barrett Bowling, Paul W Sanders, Richard M Allman, et al.
Kidney International|November 11, 2022
A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetesGeorge L Bakris, Luis M Ruilope, Stefan D Anker, et al.
European Journal of Heart Failure|December 10, 2024
Machine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fractionLuca Monzo, Emmanuel Bresso, Kenneth Dickstein, et al.
American Journal of Hypertension|August 8, 2023
What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of EvidenceKaja Sevre, Aurora Rist, Kristian Wachtell, et al.
Lancet (London, England)|February 23, 2010
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trialGeorge L Bakris, Pantelis A Sarafidis, Matthew R Weir, et al.
Blood Pressure|April 25, 2007
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular riskMichael A Weber, George L Bakris, Björn Dahlöf, et al.
Cardiovascular Drugs and Therapy|September 27, 2017
Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical OutcomesSøren L Kristensen, Pardeep S Jhund, Matthew M Y Lee, et al.
Diabetologia|November 4, 2017
Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trialJelena P Seferovic, Marc A Pfeffer, Brian Claggett, et al.
Pageof 91